Advanced

Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?

Olsson, H LU ; Bladström, A LU and Ingvar, C LU (2003) In Obstetrics and Gynecology 102(3). p.70-565
Abstract

OBJECTIVE: [corrected] To investigate the relationship between hormone replacement therapy (HRT), smoking, and cancer incidence.

METHODS: Baseline interviews were conducted from 1990 to 1992 in a population-based cohort of 29,508 Swedish women aged 25-65 years with no history of cancer. Cancer incidence in the cohort was assessed through December 31, 1999, with the Swedish Cancer Registry, the Population Census Registry, and the Cause of Death Registry.

RESULTS: When follow-up ended, the cohort included 226,611 person-years. A total of 1145 malignancies were diagnosed (observed), and 1166.6 were expected (standardized incidence ratio 0.98; 95% confidence interval [CI] 0.93, 1.04). Women who had experienced a natural... (More)

OBJECTIVE: [corrected] To investigate the relationship between hormone replacement therapy (HRT), smoking, and cancer incidence.

METHODS: Baseline interviews were conducted from 1990 to 1992 in a population-based cohort of 29,508 Swedish women aged 25-65 years with no history of cancer. Cancer incidence in the cohort was assessed through December 31, 1999, with the Swedish Cancer Registry, the Population Census Registry, and the Cause of Death Registry.

RESULTS: When follow-up ended, the cohort included 226,611 person-years. A total of 1145 malignancies were diagnosed (observed), and 1166.6 were expected (standardized incidence ratio 0.98; 95% confidence interval [CI] 0.93, 1.04). Women who had experienced a natural menopause and had ever used HRT had no increased incidence of cancer overall (standardized incidence ratio 1.03; 95% CI 0.88, 1.19). Long-term HRT users who smoked had a decreased incidence of smoking-related cancers, such as the oral cavity, pharynx, hypopharynx, larynx, esophagus, lung, cervix, and bladder (standardized incidence ratio 0.24; 95% CI 0.08, 0.76). The effect was seen regardless of the type of HRT (progestin versus non-progestin-containing preparations) used and number of cigarettes smoked. The protective role of HRT for colon cancer was evident among both smokers and nonsmokers. An increased incidence of endometrial cancer was seen only for nonsmokers who used HRT.

CONCLUSION: Our data indicate that HRT use protects women against smoking-associated cancers. This effect occurs regardless of the type of HRT and the amount of smoking.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adult, Age Distribution, Aged, Cohort Studies, Confidence Intervals, Female, Hormone Replacement Therapy, Humans, Incidence, Menopause, Middle Aged, Neoplasms, Probability, Prognosis, Proportional Hazards Models, Registries, Risk Assessment, Smoking, Survival Analysis, Sweden
in
Obstetrics and Gynecology
volume
102
issue
3
pages
6 pages
publisher
Lippincott Williams & Wilkins
external identifiers
  • wos:000185007400026
  • pmid:12962944
  • scopus:0141921343
ISSN
1873-233X
DOI
10.1016/S0029-7844(03)00564-7
language
English
LU publication?
yes
id
da5a57a6-67ee-4bb6-854c-8f3de3c1bfde (old id 117897)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12962944&dopt=Abstract
date added to LUP
2007-07-19 09:36:46
date last changed
2018-05-29 11:39:02
@article{da5a57a6-67ee-4bb6-854c-8f3de3c1bfde,
  abstract     = {<p>OBJECTIVE: [corrected] To investigate the relationship between hormone replacement therapy (HRT), smoking, and cancer incidence.</p><p>METHODS: Baseline interviews were conducted from 1990 to 1992 in a population-based cohort of 29,508 Swedish women aged 25-65 years with no history of cancer. Cancer incidence in the cohort was assessed through December 31, 1999, with the Swedish Cancer Registry, the Population Census Registry, and the Cause of Death Registry.</p><p>RESULTS: When follow-up ended, the cohort included 226,611 person-years. A total of 1145 malignancies were diagnosed (observed), and 1166.6 were expected (standardized incidence ratio 0.98; 95% confidence interval [CI] 0.93, 1.04). Women who had experienced a natural menopause and had ever used HRT had no increased incidence of cancer overall (standardized incidence ratio 1.03; 95% CI 0.88, 1.19). Long-term HRT users who smoked had a decreased incidence of smoking-related cancers, such as the oral cavity, pharynx, hypopharynx, larynx, esophagus, lung, cervix, and bladder (standardized incidence ratio 0.24; 95% CI 0.08, 0.76). The effect was seen regardless of the type of HRT (progestin versus non-progestin-containing preparations) used and number of cigarettes smoked. The protective role of HRT for colon cancer was evident among both smokers and nonsmokers. An increased incidence of endometrial cancer was seen only for nonsmokers who used HRT.</p><p>CONCLUSION: Our data indicate that HRT use protects women against smoking-associated cancers. This effect occurs regardless of the type of HRT and the amount of smoking.</p>},
  author       = {Olsson, H and Bladström, A and Ingvar, C},
  issn         = {1873-233X},
  keyword      = {Adult,Age Distribution,Aged,Cohort Studies,Confidence Intervals,Female,Hormone Replacement Therapy,Humans,Incidence,Menopause,Middle Aged,Neoplasms,Probability,Prognosis,Proportional Hazards Models,Registries,Risk Assessment,Smoking,Survival Analysis,Sweden},
  language     = {eng},
  number       = {3},
  pages        = {70--565},
  publisher    = {Lippincott Williams & Wilkins},
  series       = {Obstetrics and Gynecology},
  title        = {Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?},
  url          = {http://dx.doi.org/10.1016/S0029-7844(03)00564-7},
  volume       = {102},
  year         = {2003},
}